Table 4. Clinical characteristics between MACE group and Non-MACE group.
| Characteristics | MACE group (n = 37) | Non-MACE group (n = 492) | P value |
| Age, yrs | 62.4 ± 8.6 | 58.6 ± 10.9 | 0.049 |
| Males | 26 (70.3%) | 380 (77.2%) | 0.330 |
| Heart rate | 78.8 ± 13.0 | 72.8 ± 11.1 | 0.038 |
| Apnoea–hypopnea index events/h | 38.7 ± 21.1 | 28.3 ± 18.7 | 0.048 |
| SYNTAX score | 14.3 ± 11.1 | 7.3 ± 9.3 | 0.012 |
| Systolic pressure | 131.5 ± 18.8 | 130.1 ± 17.2 | 0.037 |
| Ejection fraction | 58.5 ± 12.9 | 62.6 ± 7.3 | 0.001 |
| Hypertensive patients | 29 (78.4%) | 352 (71.5%) | 0.372 |
| Diabetes mellitus | 18 (48.6%) | 175 (35.5%) | 0.011 |
| Dyslipidaemia | 12 (32.4%) | 226 (45.9%) | 0.101 |
| Body mass index, kg/m2 | 29.4 ± 3.6 | 27.4 ± 3.5 | 0.033 |
| Current or former smoker | 11 (29.7%) | 139 (28.3%) | 0.874 |
| Alcohol abuse | 4 (10.8%) | 29 (5.9%) | 0.233 |
| BNP, pg/mL | 79.8 ± 248.8 | 81.9 ± 213.4 | 0.874 |
| cTnI, ng/mL | 0.28 ± 0.78 | 1.3 ± 9.6 | 0.176 |
Data are presented as mean ± SD or n (%). Mann–Whitney and Chi-squared tests were used to assess the differences in the means or proportions between groups. Statistically significant P-values are shown in bold. BNP: B-type natriuretic peptide; cTnI: cardiac troponin I; MACE: major adverse cardiovascular events.